Pain-blocking gene mutation may hold clues for drug developers

Pharmaceutical researchers are studying a mutation in the SCN9A gene that makes patients immune to pain. While medications can mute pain, new experimental formulations that try to mimic the gene mutation aim to stop nerve cells from sending pain signals to the brain.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT